⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

SOLV

Solventum Corporation

Healthcare · Medical Instruments & Supplies

85.41USD

-2.0400 (-2.33%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on SOLV.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$1.34▼$1.4120
Next quarter$1.79▲$1.7811
Current year$7.14▲$6.5520
Next year$7.25▲$7.0931

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$1.91$2.55+0.64 (+33.8%)
2026-03-31$1.35$1.48+0.13 (+9.3%)
2025-12-31$1.5$1.57+0.07 (+5.0%)
2025-09-30$1.43$1.5+0.07 (+4.7%)

Wall Street coverage

61 ratings from 17 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
BTIGReiteratedBuy$95Sep 14, 2026
UBSMaintainedBuy$95 $101Aug 6, 2026
Piper SandlerMaintainedOverweight$92 $105Aug 6, 2026
WedbushMaintainedOutperform$94 $101Aug 6, 2026
KeybancMaintainedOverweight$93 $102Aug 6, 2026
StifelMaintainedBuy$90 $100Aug 6, 2026
BTIGMaintainedBuy$91 $95Aug 6, 2026
UBSUpgraded from NeutralBuy$95Jul 28, 2026
BMO CapitalInitiatedMarket Perform$81Jul 9, 2026
WedbushInitiatedOutperform$94May 15, 2026
UBSMaintainedNeutral$82 $78May 6, 2026
StifelMaintainedBuy$105 $90May 6, 2026
Wells FargoMaintainedEqual-Weight$83 $70May 6, 2026
KeybancMaintainedOverweight$92 $93May 6, 2026
BTIGReiteratedBuy$89May 6, 2026
KeybancMaintainedOverweight$99 $92Apr 27, 2026
Piper SandlerMaintainedOverweight$98 $92Apr 17, 2026
Rothschild & CoInitiatedSell$60Mar 24, 2026
Wells FargoMaintainedEqual-Weight$86 $83Feb 27, 2026
KeybancMaintainedOverweight$97 $99Feb 27, 2026
BTIGReiteratedBuy$100Feb 27, 2026
KeybancUpgraded from Sector WeightOverweight$97Jan 26, 2026
MizuhoUpgraded from NeutralOutperform$85 $100Jan 20, 2026
StifelMaintainedBuy$88 $105Jan 7, 2026
BTIGUpgraded from NeutralBuy$100Dec 2, 2025

Insider transactions

72 filings from 22 insiders · 0 buy / 0 sell over 6m

Officers and directors of SOLV, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Hanson Bryan CDirector; Officer, Chief Executive OfficerExerciseRestricted Stock Units67.3k——Sep 1, 2026
Hanson Bryan CDirector; Officer, Chief Executive OfficerTax26.5k$90.95$2.41MSep 1, 2026
Hanson Bryan CDirector; Officer, Chief Executive OfficerExercise67.3k——Sep 1, 2026
MCMILLAN WAYDE DChief Financial OfficerOther9.5k——May 13, 2026
HANSON BRYAN CRAIGChief Executive OfficerOther34.3k——May 13, 2026
KIRBERGER MARCELA A.OfficerOther4.5k——May 13, 2026
GOMEZ TAMMY LOfficerOther4.0k——May 13, 2026
LANDUCCI AMYChief Technology OfficerOther4.4k——May 13, 2026
WILCOX MARY TOfficerOther2.4k——May 13, 2026
HARRINGTON PAUL SOfficerOther4.0k——May 13, 2026
ALBAN CARLOSDirectorOther3.4k——Apr 30, 2026
DEVORE SUSAN DDirectorOther3.4k——Apr 30, 2026
WILSON DARRYL LDirectorOther3.4k——Apr 30, 2026
MILY ELIZABETHDirectorOther3.4k——Apr 30, 2026
EDWARDS SHIRLEY ANNDirectorOther3.4k——Apr 30, 2026
WEILAND JOHN HDirectorOther3.4k——Apr 30, 2026
COX CARRIE SMITHDirectorOther4.9k——Apr 30, 2026
MAY KAREN JDirectorOther3.4k——Apr 30, 2026
EISENBERG GLENN ADirectorOther3.4k——Apr 30, 2026
HARRIS BERNARD A JRDirectorOther3.4k——Apr 30, 2026

Analyst Notes

Sign in to write

No analyst notes on SOLV yet.

Top voices on SOLV

Members whose judged calls on SOLV have played out most reliably.

No settled calls on SOLV yet. Nobody has filed a call with a deadline on it.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice

Analyst Ratings

13 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current17511Hold2.60
1 mo ago17511Hold2.60
2 mo ago17511Hold2.60
3 mo ago17511Hold2.60
Price target$94.69$71.00 – $113.00
+10.9% to target